10-Q
Quarterly Report
Autonomix Medical, Inc.
AMIX
NASDAQ
CIK: 1617867
File #: 001-41940
Balance Sheet
28 line items · 2 periods
XBRL
| Item | Jun 30, 2024 | Mar 31, 2024 |
|---|---|---|
Current assets: | ||
Cash and cash equivalents | 6,751,000 | 8,608,000 |
Other current assets | 325,000 | 783,000 |
Total current assets | 7,076,000 | 9,391,000 |
Long term assets: | ||
Fixed assets, net | 19,000 | 16,000 |
Total long term assets | 19,000 | 16,000 |
Total Assets | 7,095,000 | 9,407,000 |
Current liabilities: | ||
Accounts payable | 287,000 | 492,000 |
Accrued expenses | 476,000 | 285,000 |
Total current liabilities | 763,000 | 777,000 |
Long term liabilities: | ||
Long term debt - convertible notes, net of unamortized debt discount | 1,043,000 | 1,002,000 |
The Notes - Convertible Debt | 1,043,000 | — |
Total long term liabilities | 1,043,000 | 1,002,000 |
Total Liabilities | 1,806,000 | 1,779,000 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value, 10,000,000 shares authorized as of June 30, 2024 and March 31, 2024, respectively, no shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively | 0 | 0 |
Common stock, $0.001 par value, 500,000,000 shares authorized as of June 30, 2024 and March 31, 2024, respectively, 19,242,081 and 18,846,094 shares issued and outstanding as of June 30, 2024 and March 31, 2024, respectively | 19,000 | 19,000 |
Additional paid-in capital | 46,938,000 | 46,578,000 |
Accumulated deficit | (41,668,000) | (38,969,000) |
Total Stockholders' Equity | 5,289,000 | 7,628,000 |
Preferred Stock | 0 | 0 |
Common Stock | 19,000 | 19,000 |
Additional Paid-in Capital | 46,938,000 | 46,578,000 |
Retained Earnings | (41,668,000) | (38,969,000) |
Total Liabilities and Stockholders' Equity | 7,095,000 | 9,407,000 |